1. Market Research
  2. > Healthcare Market Trends
  3. > Bahrain Pharmaceuticals and Healthcare Report Q1 2017

Bahrain Pharmaceuticals and Healthcare Report Q1 2017

  • November 2016
  • -
  • Business Monitor International
  • -
  • 72 pages

Includes 3 FREE quarterly updates


BMI View:

Bahrain, as well as the wider Gulf Cooperation Council (GCC) region, offers significant growth opportunities for pharmaceutical manufacturers, especially generic drugmakers. Sales of generic medicine will be driven by cost containment measures, growing awareness and boosts to domestic manufacturing capabilities and will increasingly penetrate the region’s pharmaceutical market. Although such measures apply downward pressure on innovative drug sales, given the preference for branded products among prescribers and consumers, patented medicines will continue to dominate prescription drug sales.

Headline Expenditure Projections



- Pharmaceuticals: BHD142mn (USD378mn) in 2015 to BHD148mn (USD393mn) in 2016; +4.0% in both local currency and US dollar terms. Forecast revised upwards from last quarter.

- Healthcare: BHD687mn (USD1.82bn) in 2015 to BHD740mn (USD1.96bn) in 2016; +7.7% in local currency terms and 7.8% in US dollar terms. Forecast unchanged from last quarter. Risk/Reward Index In our Q117 matrix for the Middle East and Africa (MEA), Bahrain scores 50.8 out of 100 and is ranked eighth out of the 33 markets surveyed in the region, just below Qatar (52.4). The country’s position is propped up by its favourable risks profile, as its longer-term rewards potential remains weighed down by its small population and market size (Market Expenditure score of 2.0 out 20.0). On the other hand, Bahrain’s well-developed business environment and demographic and epidemiological trends will continue to provide commercial opportunities for innovative drugmakers.

Table Of Contents

Bahrain Pharmaceuticals and Healthcare Report Q1 2017
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Bahrain 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Bahrain 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Bahrain 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Bahrain 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Bahrain 2012-2020) 17
Prescription Drug forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Bahrain 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Bahrain 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bahrain 2012-2020) 23
OTC Drug Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Bahrain 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Bahrain 2014-2020) 27
Table: Pharmaceutical Trade Data And Forecasts Local Currency (Bahrain 2014-2020) 28
Pharmaceuticals Risk/Reward Index 29
Middle East And Africa Risk/Reward Index - Q1 2017 29
Bahrain Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Intellectual Property Issues 42
Pricing And Reimbursement Regime 43
Public Sector Procurement 44
Free Trade Agreements 44
Market Overview 47
Healthcare Sector 48
Healthcare Sector Developments 48
Healthcare Provision 48
Table: Ministry Of Health's Objectives 49
Health Insurance 50
Health Insurance For Expatriates 51
Table: National Health Insurance Scheme Breakdown 51
Research And Development 53
Clinical Trials 53
Epidemiology 54
Competitive Landscape 57
Research-Based Industry 57
Table: Multinational Market Activity 57
Generic Drugmakers 58
Pharmaceutical Distribution 59
Pharmaceutical Retail Sector 60
Demographic Forecast 61
Demographic Outlook 61
Table: Population Headline Indicators (Bahrain 1990-2025) 62
Table: Key Population Ratios (Bahrain 1990-2025) 62
Table: Urban/Rural Population and Life Expectancy (Bahrain 1990-2025) 63
Table: Population By Age Group (Bahrain 1990-2025) 63
Table: Population By Age Group % (Bahrain 1990-2025) 64
Glossary 66
Methodology 68
Pharmaceutical Expenditure Forecast Model 68
Healthcare Expenditure Forecast Model 68
Notes On Methodology 69
Risk/Reward Index Methodology 70
Index Overview 71
Table: Pharmaceutical Risk/Reward Index Indicators 71
Indicator Weightings 72

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-El ...

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro- ...

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical ...


Download Unlimited Documents from Trusted Public Sources

Public Health Industry in the UK

  • December 2016
    156 pages
  • Public Health  

    Neurological Di...  

    Hospital  

  • United Kingdom  

View report >

Public Health Markets in the UK

  • December 2016
    45 pages
  • Public Health  

    Obesity  

    Food  

  • United Kingdom  

    Europe  

View report >

Breast Cancer Statistics in Africa

  • December 2016
    14 pages
  • Breast Cancer  

  • Africa  

View report >

Related Market Segments :

Healthcare
Pharmaceutical

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.